In hepatocellular carcinoma (HCC) and endometrial cancer, ADM contributes to resistance against hypoxic apoptosis and fosters cell proliferation by upregulating the anti-apoptotic protein Bcl-2 [69,70]. The gene discussed is BCL2; the disease is hepatocellular carcinoma.